NCT05419908View on ClinicalTrials.gov

Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes

PHASE2CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

September 21, 2015

Primary Completion Date

September 21, 2016

Study Completion Date

October 6, 2016

Conditions
Hot Flashes
Interventions
DRUG

Fezolinetant

Oral Capsule

DRUG

Placebo

Oral Capsule

Trial Locations (8)

1000

Site BE32004, Brussels

1090

Site BE32006, Jette

1950

Site BE32005, Kraainem

3300

Site BE32009, Tienen

3600

Site BE32003, Genk

7000

Site BE32008, Mons

9000

Site BE32001, Ghent

Unknown

Site BE32007, Leuven

All Listed Sponsors
lead

Ogeda S.A.

INDUSTRY

NCT05419908 - Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes | Biotech Hunter | Biotech Hunter